Vaughan, Ontario-headquartered CannTrust Holdings Inc. (CannTrust), one of Canada's leading licenced producers of cannabis, has shipped its standardized cannabidiol oil capsules to Australia's Gold Coast University Hospital. The capsules will be used in a study to determine the efficacy of CannTrust's capsules in slowing the disease progression in patients with Amyotrophic Lateral Sclerosis and Motor Neuron Disease. The capsules will be imported, stored, and distributed by Oak Park, Illinois-headquartered PharmaCann Pty. Ltd. The shipment will include all investigational products that are required for the study. CannTrust is a federally regulated licenced producer of medical and recreational cannabis and is Canada's only pharmacist-founded medical cannabis producer.